View Press Releases
-
Integrated DNA Technologies Introduces New HIV Panel to Advance Virology Research
Advancing virology research: IDT's xGen™ HIV Amplicon Panel consisting of primers designed to cover 99.3% of the HIV genome is now available.
Jun 23, 2024
-
Proscia And Nucleai Partner To Broaden Access To AI Predictive Biomarkers
Expanding Proscia’s precision medicine AI pipeline will help to optimize clinical trials and improve treatment decisions
Jun 24, 2024
-
Argonaut Partner to Offer Accelerated End-to-End Drug Development Support for Biopharmaceutical Companies
Biopharma gains a seamless transition from drug discovery through drug product manufacturing
Jun 20, 2024
-
ResultsCX Wins Two 2024 Fortress Cybersecurity Awards
-
Aranscia and Signature RX Announce Personalized Medication Management Program for GLP-1s
-
Bora Pharmaceuticals Expands North American Footprint with Agreement to Acquire First Sterile Manufacturing Facility
-
Clinion and Clinevo’s Strategic Alliance for An Integrated eClinical Experience
AI-powered eClinical Platform, Clinion, announces strategic partnership with eClinical safety solutions provider, Clinevo.
Jun 19, 2024
-
ZeOmega Launches HealthFeed SMS Texting for Enhanced Member Engagement
-
Cresset Successfully Achieves SOC 2 Compliance
-
AKASA Unveils AKASA Medical CodingTM for Enhanced Revenue Cycle Management with Generative AI
-
TP-ACO Selects YouScript for Personalized Medication Management Initiative
-
Instem And Proscia Partner To Accelerate Preclinical Development With Digital Pathology
Instem, a leading provider of IT solutions and services to the global life sciences market, has partnered with Proscia®, a global leader in AI-enhanced pathology solutions for precision medicine.
Jun 16, 2024
-
CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations
CluePoints Continues ‘Turning Artificial Intelligence into Human Intelligence’ by Launching Two New Innovations Site Profile & Oversight Tool (SPOT) and Intelligent Medical Coding (IMC) unveiled by RBQM innovator at DIA Global Annual Meeting 2024
Jun 16, 2024
-
ProPharma Honored with 2024 CRO Leadership Award
ProPharma, the world’s largest research consulting organization (RCO), a leading global provider of regulatory, clinical, and compliance services for the life sciences industry is pleased to announce it received a 2024 CRO Leadership Award.
Jun 12, 2024
-
Huateng Pharma to Exhibit at CPHI China 2024
-
New Research Illustrates How to Drive Earlier Diagnosis and Treatment of Kidney Disease
A new survey by Phreesia, in partnership with the National Kidney Foundation, finds that discussions between patients and providers, and patient activation, are key to helping high-risk patients take preventive actions to manage their kidney health.
Jun 9, 2024
-
Uppsala University Hospital chooses AI-based Qlucore Insights to develop precision diagnostics
Please see latest news from Qlucore who has signed an agreement with Uppsala University Hospital. The Hospital will use the Qlucore Insights software to improve the analysis of acute lymphoblastic leukemia (ALL) in children. Please get in touch if you require further information.
Jun 11, 2024
-
Onyx Scientific Aims for European Growth with New BD Hire
Small molecule specialists Onyx Scientific has made a significant new addition to its commercial team with the appointment of Courtnie Thomas Wilks as Business Development Manager for the UK and Europe.
Jun 12, 2024
-
MIB Agents’ Community of Families Has Awarded Over $1.9M in Grants to Research Pediatric Bone Cancer
-
Mage Biologics announces first subject dosed in a Phase 1 trial with MB-001, an orally administered antibody for Inflammatory Bowel Disease
Mage Biologics (“Mage”) announces it has dosed the first study participant in a first-in-human study of MB-001, a best-in-class orally administered antibody designed for the treatment of inflammatory bowel disease (IBD).
Jun 11, 2024